| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $158.2M | +6.4% | +15.3% |
| Cost of Revenue | $65.9M | -2.5% | +5.5% |
| Gross Profit | $92.3M | +13.8% | +23.5% |
| R&D Expense | $41.4M | -1.9% | +29.9% |
| SG&A Expense | $29.7M | +22.1% | +9.3% |
| Operating Income | -$28.8M | +22.1% | +29.1% |
| Interest Expense | $3.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $113.1M | +37.2% | -48.0% |
| Short-term Investments | $229.8M | -3.7% | +153.2% |
| Accounts Receivable | $109.2M | -6.9% | -6.5% |
| Current Assets | $479.8M | +3.3% | +5.9% |
| Total Assets | $1.47B | +0.5% | -0.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $72.0M | — | — |
| Capital Expenditures | $18.5M | — | — |
| Investing Cash Flow | -$249.2M | — | — |
| Financing Cash Flow | $3.9M | — | — |
| Free Cash Flow | $53.5M | — | — |
| +0.0% |
| +700.0% |
| Pre-tax Income | -$28.9M | +21.8% | +23.0% |
| Income Tax | $559K | +0.4% | +22.9% |
| Net Income | -$29.5M | +21.5% | +22.4% |
| EPS (Basic) | -$0.20 | +23.1% | +25.9% |
| EPS (Diluted) | -$0.20 | +23.1% | +25.9% |
| $328.9M |
| +5.2% |
| +188.0% |
| Long-term Debt | $149.9M | +0.0% | -56.5% |
| Total Liabilities | $533.6M | +2.5% | +6.2% |
| Stockholders' Equity | $937.0M | -0.6% | -3.4% |